Evidence map›Paper›PMID 34576268›Full record

ReviewInternational journal of molecular sciences2021

Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.

Wei Du, Yiru Gao, Li Liu, Sixiang Sai, Chen Ding

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  14. Review
  15. Lecithin and Chitosan as Building Blocks in Anti-Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. AgPharmaceuticals (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei DuCollege of Life and Health Sciences, Northeastern University, Shenyang 110015, China.
Yiru GaoCollege of Life and Health Sciences, Northeastern University, Shenyang 110015, China.
Li LiuCollege of Life and Health Sciences, Northeastern University, Shenyang 110015, China.
Sixiang SaiSchool of Medicine, Binzhou Medical University, Yantai 264003, China.
Chen DingCollege of Life and Health Sciences, Northeastern University, Shenyang 110015, China.ORCID 0000-0002-9195-2255

Funding

Fundamental Research Funds for the Central Universities N142005001 and N172002001Liaoning Revitalization Talents Program XLYC1807001National Natural Science Foundation of China 31870140
6 · The paper itself

Abstract

Fungal infections have become a major health concern, given that invasive infections by

Indexed as

NanomedicineAntifungal AgentsAspergillosisAspergillusAzolesCandidaCandidiasisCryptococcosisCryptococcusDrug Delivery SystemsDrug DesignDrug Resistance, FungalEchinocandinsLipidsMetal NanoparticlesMicrobial Sensitivity TestsAntifungal AgentsAzolesEchinocandinsLipidsPolyenesPolymersSilicon Dioxideantifungal therapiesfungal infectionnanosystems

Identifiers

PMID34576268
PMCPMC8466259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.